ORGANOGENESIS HOLDINGS INC. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
ORGANOGENESIS HOLDINGS INC. (ORGO) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $15.06 million as of 2020-12-31, per its 10-Q filed 2021-05-11.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2021-05-11
- 2020-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $15.06M.
- 2020-09-30: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $15.71M.
- 2020-06-30: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $16.34M.
- 2020-03-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $16.94M.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2020-12-31 | $15.06M 10-Q · filed 2021-05-11 |
| 2020-09-30 | $15.71M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $16.34M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $16.94M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $17.49M 10-K · filed 2020-03-09 |
| 2019-09-30 | $17.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $17.10M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $17.45M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $17.66M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |